HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011

for the NHBS study group

doi:10.1016/j.vaccine.2014.09.033

HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011

for the NHBS study group

Mailman School of Public Health

Résultat de recherche › examen par les pairs

42 Citations (Scopus)

Résumé

Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

Langue d'origine	English
Pages (de-à)	6356-6359
Nombre de pages	4
Journal	Vaccine
Volume	32
Numéro de publication	48
DOI	https://doi.org/10.1016/j.vaccine.2014.09.033
Statut de publication	Published - nov. 12 2014

Financement

This study was funded by CDC. The authors thank all of the 2011 NHBS participants, Nevin Krishna, Brooke Hoots, and Teresa Finlayson (Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC) for their assistance.

Bailleurs de fonds	Numéro du bailleur de fonds
Centers for Disease Control and Prevention

ASJC Scopus Subject Areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/j.vaccine.2014.09.033

Autres fichiers et liens

Citer

@article{390cfe52a3174845bcc196b9bdafb0da,

title = "HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011",

abstract = "Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.",

author = "{for the NHBS study group} and Elissa Meites and Markowitz, {Lauri E.} and Gabriela Paz-Bailey and Oster, {Alexandra M.} and Jianglan White and Jeff Todd and Greg Bautista and Colin Flynn and Danielle German and Maura Miminos and Rose Doherty and Chris Wittke and Nikhil Prachand and Nanette Benbow and Sharon Melville and Shane Sheu and Alicia Novoa and Mark Thrun and Alia Al-Tayyib and Ralph Wilmoth and Vivian Griffin and Emily Higgins and Karen MacMaster and Marcia Wolverton and Hafeez Rehman and Paige Padgett and Trista Bingham and Sey, {Ekow Kwa} and Marlene LaLota and Lisa Metsch and David Forrest and Anderson, {Bridget J.} and Watson, {Carol Ann} and Lou Smith and Gruber, {De Ann} and Robinson, {William T.} and Narquis Barak and Alan Neai-gus and Reilly, {Kathleen H.} and Travis Wendel and Barbara Bolden and Afework Wogayehu and Henry Godette and Brady, {Kathleen A.} and Andrea Sifferman and Vanessa Miguelino-Keasling and Al Velasco and Veronica Tovar and Raymond, {H. Fisher} and {De Le{\'o}n}, {Sandra Miranda}",

note = "Publisher Copyright: {\textcopyright} 2014.",

year = "2014",

month = nov,

day = "12",

doi = "10.1016/j.vaccine.2014.09.033",

language = "English",

volume = "32",

pages = "6356--6359",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "48",

}

TY - JOUR

T1 - HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011

AU - for the NHBS study group

AU - Meites, Elissa

AU - Markowitz, Lauri E.

AU - Paz-Bailey, Gabriela

AU - Oster, Alexandra M.

AU - White, Jianglan

AU - Todd, Jeff

AU - Bautista, Greg

AU - Flynn, Colin

AU - German, Danielle

AU - Miminos, Maura

AU - Doherty, Rose

AU - Wittke, Chris

AU - Prachand, Nikhil

AU - Benbow, Nanette

AU - Melville, Sharon

AU - Sheu, Shane

AU - Novoa, Alicia

AU - Thrun, Mark

AU - Al-Tayyib, Alia

AU - Wilmoth, Ralph

AU - Griffin, Vivian

AU - Higgins, Emily

AU - MacMaster, Karen

AU - Wolverton, Marcia

AU - Rehman, Hafeez

AU - Padgett, Paige

AU - Bingham, Trista

AU - Sey, Ekow Kwa

AU - LaLota, Marlene

AU - Metsch, Lisa

AU - Forrest, David

AU - Anderson, Bridget J.

AU - Watson, Carol Ann

AU - Smith, Lou

AU - Gruber, De Ann

AU - Robinson, William T.

AU - Barak, Narquis

AU - Neai-gus, Alan

AU - Reilly, Kathleen H.

AU - Wendel, Travis

AU - Bolden, Barbara

AU - Wogayehu, Afework

AU - Godette, Henry

AU - Brady, Kathleen A.

AU - Sifferman, Andrea

AU - Miguelino-Keasling, Vanessa

AU - Velasco, Al

AU - Tovar, Veronica

AU - Raymond, H. Fisher

AU - De León, Sandra Miranda

PY - 2014/11/12

Y1 - 2014/11/12

N2 - Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

AB - Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

UR - http://www.scopus.com/inward/record.url?scp=84908620131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908620131&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2014.09.033

DO - 10.1016/j.vaccine.2014.09.033

M3 - Article

C2 - 25258097

AN - SCOPUS:84908620131

SN - 0264-410X

VL - 32

SP - 6356

EP - 6359

JO - Vaccine

JF - Vaccine

IS - 48

ER -

HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011

Résumé

Financement

ASJC Scopus Subject Areas

ODD de l’ONU

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer